Original Research
This retrospective multicentre audit aimed to evaluate the achievement of lipid-lowering targets with bempedoic acid in UK patients based on recommendations in the Joint British Societies (JBS) guidelines for the prevention of cardiovascular disease.
Review
This review aims to present and discuss the current clinical and scientific data pertaining to the new and emerging lipid-modifying low-density lipoprotein-cholesterol-lowering drugs.
Review
This narrative review aims to present and discuss the current evidence regarding the use of bempedoic acid for low-density lipoprotein-cholesterol lowering in patients with dyslipidemia and its potential role as an agent to lower cardiovascular events.
